HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.

HelloHYQVIA

HelloHYQVIA
Free Trial Program.

Learn if HYQVIA is right for your patients with PI with the HelloHYQVIA Free Trial Program.

Help your eligible* adult PI patients see if HYQVIA is right for them. With HelloHYQVIA, the entire cost of their first 3 infusions of HYQVIA during the ramp-up period, along with ancillary supplies, pump, and administration are all covered.

Get your eligible patients started today by following the process below. If there are any questions during the process, call 1-866-888-0660 for assistance. It may take several weeks until the patient has the product and the first infusion is scheduled.

  1. Download and complete the HelloHYQVIA Free Trial Request Form and fax to 1-833-388-5467. Physician can check box on form if they want to have the pharmacist determine ramp-up dosing.

    • Please note the pharmacist will call the physician’s office to clarify ramp-up dosing if it is not written or the box isn’t checked
  2. Patient will receive a Welcome Call from a HelloHYQVIA Free Trial Case Manager.

    The Case Manager will:

    • Ensure that the patient has signed the HelloHYQVIA Form
    • Connect the patient with the specialty pharmacy that will coordinate medication shipment
    • Connect the patient with a nurse who will help schedule in-home administration training
  3. The patient will receive their first three (3) ramp-up HYQVIA infusions either at home or in the office, depending on what you choose. After completion of the program, communication will be sent to the physician documenting the infusion rate and patient experience.

*Eligible patients must have an ICD-10 code verifying diagnosis of PI and be a new patient not currently using HYQVIA who has not previously enrolled in the HelloHYQVIA Program. Additional Terms apply.